Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas

Table 2

Correlation between CD44v6 protein expression and various clinicopathologic parameters.

Clinicopathologic parameters	Number of cases	CD44v6-positive cases (%)	P value
Age; ⩽ 50; > 50	21; 41	13 (61.9); 28 (68.3)	> 0.05
Menopausal status; Premenopausal; Postmenopausal	17; 45	11 (64.7); 30 (66.7)	> 0.05
Nulliparous status; Yes; No; Serous	9; 53; 45	6 (66.7); 35 (66.0); 32 (71.1)	> 0.05
Histological type; Mucinous; Endometrioid; Undifferentiated	5; 8; 4	2 (40); 3 (37.5); 4 (100)	> 0.05
FIGO stage; I; II; III; IV	16; 23; 15; 8	5 (31.2); 18 (78.2); 11 (73.3); 7 (87.5)	< 0.05
Grade; I; II; III	19; 32; 11	6 (52.6); 25 (65.6); 10 (90.9)	< 0.05
Survival period; ≤ 5; > 5	33; 29	26 (78.8); 15 (51.7)	< 0.05